Molecular imaging using PET for breast cancer

Area of Science:

• Oncology
• Medical Imaging
• Molecular Biology

Background:

• Molecular imaging visualizes in vivo biological processes at molecular and cellular levels.
• Various modalities exist for breast cancer imaging, but Positron Emission Tomography (PET) offers high sensitivity and non-invasive assessment.
• Specific molecular targets can be visualized using targeted tracers.

Purpose of the Study:

• To review the application of Positron Emission Tomography (PET) in molecular imaging of breast cancer.
• To focus on the utility of specific PET tracers in breast cancer diagnosis and management.

Main Methods:

• Review of existing literature on PET molecular imaging in breast cancer.
• Focus on established and emerging PET tracers including FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.

Main Results:

• PET enables sensitive visualization of molecular and cellular processes in breast cancer.
• Specific tracers like FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET provide valuable diagnostic and prognostic information.
• PET facilitates non-invasive assessment of breast cancer characteristics.

Conclusions:

• Positron Emission Tomography (PET) is a powerful tool for molecular imaging in breast cancer.
• The reviewed PET tracers offer diverse applications for understanding breast cancer biology and guiding treatment decisions.